Anti-egfr antibody drug conjugate formulations

Discloses lyophilized pharmaceutical formualtions comprising an anti-EGFR antibody drug conjugate (ADC). The antibody has the HCDR sequences of SEQ ID NO: 15-17 and the LCDRs of SEQ ID NO: 20-22 or the HCVR of SEQ ID NO: 13 and the LCVR of SEQ ID NO: 18. The auristatin can be monomethylauristatin F...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Markus Tschoepe, Katharina Kaleta, Vineet Kumar
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!